NCT01006499

Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'

Phase 4 Study of Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 204 (estimated)
• Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
• Sex: All
• Age: 1 Day – 90 Days
• Healthy volunteers: Not accepted

Summary

The investigators aim is to investigate whether adjuvant Pentoxifylline , IgM enriched IVIG or Pentoxifylline plus IgM-enriched IVIG reduced mortality from Neonatal sepsis.

Conditions

• Sepsis of the Newborn

Interventions

Type	Name	Description
DRUG	Pentoxifylline, pentaglobin	Pentaglobin 250mg/kg/d over 4 hour for three days Pentoxyfilline 6mg/kg/h over 4 hour for three days Pentaglobin 250mg/kg/d over 4 hour for three days+Pentoxyfilline 6mg/kg/h over 4 hour for three days Placebo (normal saline 5ml/kg over 4 hour for three days

Timeline

• Start date: 2009-08-01
• Primary completion: 2010-10-01
• Completion: 2010-12-01
• First posted: 2009-11-02
• Last updated: 2011-03-11

Locations

1 site across 1 country: Turkey (Türkiye)